Abstract
Breast cancer affects one out of every 10 women in industrialized countries, and is a leading cause of cancer morbidity and mortality in women. Ovarian cancer, although less common than breast cancer, is very difficult to treat effectively, in part due to difficulty in early diagnosis of the disease. Most cases of breast or ovarian cancer appear to occur without a clear family history of the disease. These sporadic cases account for approximately 95% of all breast cancer. Possibly, low-penetrance genes contribute as risk factors to this group of cancers. However, about 5% of breast cancers occur clustered within families. Importantly, cancer in these familial syndromes characteristically manifests at a younger age than sporadic cancer. Therefore, in terms of both the number of women affected and the effect of disease on individual families, the familial breast and/or ovarian cancer syndromes have a large impact upon society. Over the past few years, the genetic basis of familial breast and ovarian cancer has become clear. It is caused by germline mutations affecting one of two autosomal tumor suppressor genes, BRCA1 and BRCA2. Surprisingly, these two genes have been found to participate in the control of homologous recombination, suggesting that they may function as tumor suppressors by regulating genome integrity maintenance functions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Broca, P. (1866) Influence héréditaire, Traité des tumeurs (Asselin, P., ed.), Tome premier: Des tumeurs en général, Paris.
Hall, J. M., et al. (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684–1689.
Narod, S. A., et al. (1991) Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet 338, 82–83.
Smith, S. A., Easton, D. F., Evans, D. G., and Ponder, B. A. (1992) Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat. Genet. 2, 128–131.
Neuhausen, S. L. and Marshall, C. J. (1994) Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res. 54, 6069–6072.
Cornelis, R. S., et al. (1995) High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium. Genes Chromosomes Cancer 13, 203–210.
Knudson, A. G., Jr. (1971) Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68, 820–823.
Miki, Y., et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66–71.
Futreal, P. A., et al. (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266, 120–122.
Castilla, L. H., et al. (1994) Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat. Genet. 8, 387–391.
Simard, J., et al. (1994) Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat. Genet. 8, 392–398.
Friedman, L. S., et al. (1994) Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat. Genet. 8, 399–404.
BIC. (2001) Breast Cancer Information Core. http://www.nhgri.nih.gov/Intramural_research/Lab_transfer/Bic/ .
Wooster, R., et al. (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265, 2088–2090.
Wooster, R., et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789–792.
Lancaster, J. M., et al. (1996) BRCA2 mutations in primary breast and ovarian cancers. Nat. Genet. 13, 238–240.
Marcus, J. N., et al. (1996) Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77, 697–709.
Lakhani, S. R., et al. (1998) Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J. Natl. Cancer Inst. 90, 1138–1145.
Lakhani, S. R. (1999) The pathology of hereditary breast cancer. Dis. Markers 15, 113–114.
Foulkes, W. D., Wong, N., Brunet, J. S., and Narod, S. A. (1998) BRCA mutations and survival in breast cancer. J. Clin. Oncol. 16, 3206–3208.
Gaffney, D. K., et al. (1998) Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations. Radiother. Oncol. 47, 129–136.
Wagner, T. M., et al. (1998) BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics. Int. J. Cancer 77, 354–360.
Osin, P. P. and Lakhani, S. R. (1999) The pathology of familial breast cancer: Immunohistochemistry and molecular analysis. Breast Cancer Res. 1, 36–40.
Hedenfalk, I., et al. (2001) Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 344, 539–548.
Wilson, C. A., et al. (1999) Localization of human BRCA1 and its loss in high-grade, noninherited breast carcinomas. Nat. Genet. 21, 236–240.
Dobrovic, A. and Simpfendorfer, D. (1997) Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res. 57, 3347–3350.
Magdinier, F., Ribieras, S., Lenoir, G. M., Frappart, L., and Dante, R. (1998) Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region. Oncogene 17, 3169–3176.
Rice, J. C., Massey-Brown, K. S., and Futscher, B. W. (1998) Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene 17, 1807–1812.
Welcsh, P. L., Owens, K. N., and King, M. C. (2000) Insights into the functions of BRCA1 and BRCA2. Trends Genet. 16, 69–74.
Wilson, C. A., et al. (1997) Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b. Oncogene 14, 1–16.
Huber, L. J., et al. (2001) Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci. Mol. Cell. Biol. 21, 4005–4015.
Puget, N., et al. (1999) An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation? Am. J. Hum. Genet. 64, 300–302.
Unger, M. A., et al. (2000) Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. Am. J. Hum. Genet. 67, 841–850.
Payne, S. R., Newman, B., and King, M. C. (2000) Complex germline rearrangement of BRCA1 associated with breast and ovarian cancer. Genes Chromosomes Cancer 29, 58–62.
Welcsh, P. L. and King, M. C. (2001) BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum. Mol. Genet. 10, 705–713.
Orelli, B. J., Logsdon, J. M., Jr., and Bishop, D. K. (2001) Nine novel conserved motifs in BRCA1 identified by the chicken orthologue. Oncogene 20, 4433–4438.
Joukov, V., Chen, J., Fox, E. A., Green, J. B., and Livingston, D. M. (2001) Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development. Proc. Natl. Acad. Sci. USA 98, 12078–12083.
Wagner, T. M., et al. (1999) Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations. Hum. Mol. Genet. 8, 413–423.
Lorick, K. L., et al. (1999) RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. USA 96, 11364–11369.
Wu, L. C., et al. (1996) Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat. Genet. 14, 430–440.
Jin, Y., et al. (1997) Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. Proc. Natl. Acad. Sci. USA 94, 12075–12080.
Brzovic, P. S., Rajagopal, P., Hoyt, D. W., King, M. C., and Klevit, R. E. (2001) Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat. Struct. Biol. 8, 833–837.
Koonin, E. V., Altschul, S. F., and Bork, P. (1996) BRCA1 protein products⋯Functional motifs. Nat. Genet. 13, 266–268.
Bork, P., et al. (1997) A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11, 68–76.
Callebaut, I. and Mornon, J. P. (1997) From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett. 400, 25–30.
Brzovic, P. S., Meza, J. E., King, M. C., and Klevit, R. E. (2001) BRCA1 RING domain cancer-predisposing mutations: structural consequences and effects on protein–protein interactions. J. Biol. Chem. 28, 28.
Williams, R. S., Green, R., and Glover, J. N. (2001) Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1. Nat. Struct. Biol. 8, 838–842.
Cortez, D., Wang, Y., Qin, J., and Elledge, S. J. (1999) Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science 286, 1162–1166.
Tibbetts, R. S., et al. (2000) Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 14, 2989–3002.
Scully, R. and Livingston, D. M. (2000) In search of the tumor suppressor functions of BRCA1 and BRCA2. Nature 408, 429–432.
Hakem, R., et al. (1996) The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85, 1009–1023.
Ludwig, T., Chapman, D. L., Papaioannou, V. E., and Efstratiadis, A. (1997) Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11, 1226–1241.
Hakem, R., de la Pompa, J. l., Elia, A., Potter, J., and Mak, T. W. (1997) Partial rescue of Brca1 (5–6) early embryonic lethality by p53 or p21 null mutation. Nat. Genet. 16, 298–302.
Sharan, S. K., et al. (1997) Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386, 804–810.
Suzuki, A., et al. (1997) Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev. 11, 1242–1252.
Scully, R., et al. (1996) Location of BRCA1 in human breast and ovarian cancer cells. Science 272, 123–126.
Scully, R., et al. (1997) Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88, 265–275.
Scully, R., et al. (1997) Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90, 425–435.
Mizuta, R., et al. (1997) RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein. Proc. Natl. Acad. Sci. USA 94, 6927–6932.
Wong, A. K., Pero, R., Ormonde, P. A., Tavtigian, S. V., and Bartel, P. L. (1997) RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J. Biol. Chem. 272, 31941–31944.
Chen, P. L., et al. (1998) The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc. Natl. Acad. Sci. USA 95, 5287–5292.
Sarkisian, C. J., Master, S. R., Huber, L. J., Ha, S. I., and Chodosh, L. A. (2001) Analysis of murine brca2 reveals conservation of protein-protein interactions but differences in nuclear localization signals. J. Biol. Chem. 276, 37640–37648.
Chen, J., et al. (1998) Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol. Cell 2, 317–328.
Rajan, J. V., Wang, M., Marquis, S. T., and Chodosh, L. A. (1996) Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc. Natl. Acad. Sci. USA 93, 13078–13083.
Rajan, J. V., Marquis, S. T., Gardner, H. P., and Chodosh, L. A. (1997) Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Dev. Biol. 184, 385–401.
Lim, D. S. and Hasty, P. (1996) A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell Biol. 16, 7133–7143.
Baumann, P., Benson, F. E., and West, S. C. (1996) Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. Cell 87, 757–766.
Shinohara, A., Ogawa, H., and Ogawa, T. (1992) Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein. Cell 69, 457–470.
West, S. C., Cassuto, E., and Howard-Flanders, P. (1981) Homologous pairing can occur before DNA strand separation in general genetic recombination. Nature 290, 29–33.
Sung, P. (1994) Catalysis of ATP-dependent homologous DNA pairing and strand exchange by yeast RAD51 protein. Science 265, 1241–1243.
Roeder, G. S. (1997) Meiotic chromosomes: it takes two to tango. Genes Dev. 11, 2600–2621.
Zhong, Q., et al. (1999) Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science 285, 747–750.
Wu, X., et al. (2000) Independence of R/M/N focus formation and the presence of intact BRCA1. Science 289, 11a.
Wang, Y., et al. (2000) BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14, 927–939.
Shen, S. X., et al. (1998) A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene 17, 3115–3124.
Foray, N., et al. (1999) Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene 18, 7334–7342.
Scully, R., et al. (1999) Genetic analysis of BRCA1 function in a defined tumor cell line. Mol. Cell 4, 1093–1099.
Cantor, S. B., et al. (2001) BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105, 149–160.
Kanaar, R., Hoeijmakers, J. H., and van Gent, D. C. (1998) Molecular mechanisms of DNA double strand break repair. Trends Cell Biol. 8, 483–489.
Paques, F. and Haber, J. E. (1999) Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 63, 349–404.
Karran, P. (2000) DNA double strand break repair in mammalian cells. Curr. Opin. Genet. Dev. 10, 144–150.
Moynahan, M. E., Chiu, J. W., Koller, B. H., and Jasin, M. (1999) Brca1 controls homology-directed DNA repair. Mol. Cell 4, 511–518.
Moynahan, M. E., Pierce, A. J., and Jasin, M. (2001) BRCA2 is required for homology-directed repair of chromosomal breaks. Mol. Cell 7, 263–272.
Moynahan, M. E., Cui, T. Y., and Jasin, M. (2001) Homology-directed dna repair, mito-mycinc resistance, and chromosome stability is restored with correction of a Brca1 mutation. Cancer Res. 61, 4842–4850.
Tutt, A., et al. (2001) Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences. EMBO J. 20, 4704–4716.
Xia, F., et al. (2001) Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining. Proc. Natl. Acad. Sci. USA 98, 8644–8649.
Patel, K. J., et al. (1998) Involvement of Brca2 in DNA repair. Mol. Cell 1, 347–357.
Mak, T. W., et al. (2000) Brcal required for T cell lineage development but not TCR loci rearrangement. Nat. Immunol. 1, 77–82.
Paull, T. T., Cortez, D., Bowers, B., Elledge, S. J., and Gellert, M. (2001) Direct DNA binding by Brca1. Proc. Natl. Acad. Sci. USA 98, 6086–6091.
Ruffner, H., Joazeiro, C. A., Hemmati, D., Hunter, T., and Verma, I. M. (2001) Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc. Natl. Acad. Sci. USA 98, 5134–5139.
Garcia-Higuera, I., et al. (2001) Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7, 249–262.
Marmorstein, L. Y., et al. (2001) A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression. Cell 104, 247–257.
Davies, A. A., et al. (2001) Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol. Cell 7, 273–282.
Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., and Bonner, W. M. (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273, 5858–5868.
Rogakou, E. P., Boon, C., Redon, C., and Bonner, W. M. (1999) Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146, 905–916.
Paull, T. P., et al. (2000) A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10, 886–895.
Fuks, F., Milner, J., and Kouzarides, T. (1998) BRCA2 associates with acetyltransferase activity when bound to P/CAF. Oncogene 17, 2531–2534.
Yarden, R. I. and Brody, L. C. (1999) BRCA1 interacts with components of the histone deacetylase complex. Proc. Natl. Acad. Sci. USA 96, 4983–4988.
Bochar, D. A., et al. (2000) BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 102, 257–265.
Thomas, J. E., Smith, M., Tonkinson, J. L., Rubinfeld, B., and Polakis, P. (1997) Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage. Cell Growth Differ. 8, 801–809.
Scully, R., Puget, N., and Vlasakova, K. (2000) DNA polymerase stalling, sister chromatid recombination and the BRCA genes. Oncogene 19, 6176–6183.
Cox, M. M., et al. (2000) The importance of repairing stalled replication forks. Nature 404, 37–41.
Kowalczykowski, S. C. (2000) Initiation of genetic recombination and recombination-dependent replication. Trends Biochem. Sci. 25, 156–165.
Zhou, B.-B. S., and Elledge, S. J. (2000) The DNA damage response: putting checkpoints in perspective. Nature 408, 433–439.
Cordeiro-Stone, M., Makhov, A. M., Zaritskaya, L. S., and Griffith, J. D. (1999) Analysis of DNA replication forks encountering a pyrimidine dimer in the template to the leading strand. J. Mol. Biol. 289, 1207–1218.
Brodie, S. G. and Deng, C. X. (2001) BRCA1-associated tumorigenesis: what have we learned from knockout mice? Trends Genet. 17, S18–S22.
Connor, F., et al. (1997) Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat. Genet. 17, 423–430.
Lee, H., et al. (1999) Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2. Mol. Cell 4, 1–10.
Xu, X., et al. (1999) Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet. 22, 37–43.
Ludwig, T., Fisher, P., Ganesan, S., and Efstratiadis, A. (2001) Tumorigenesis in mice carrying a truncating Brca1 mutation. Genes Dev. 15, 1188–1193.
Ludwig, T., Fisher, P., Murty, V., and Efstratiadis, A. (2001) Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice. Oncogene 20, 3937–3948.
Xu, X., et al. (2001) Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat. Genet. 28, 266–271.
Smith, P. D., et al. (1999) Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions. Oncogene 18, 2451–2459.
Brodie, S. G., et al. (2001) Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice. Oncogene 20, 7514–7523.
Monteiro, A. N. (2000) BRCA1: exploring the links to transcription. Trends Biochem. Sci. 25, 469–474.
Parvin, J. D. (2001) BRCA1 at a branch point. Proc. Natl. Acad. Sci. USA 98, 5952–5954.
Irminger-Finger, I., Siegel, B. D., and Leung, W. C. (1999) The functions of breast cancer susceptibility gene 1 (BRCA1) product and its associated proteins. Biol. Chem. 380, 117–128.
Deng, C. X. and Brodie, S. G. (2000) Roles of BRCA1 and its interacting proteins. Bioessays 22, 728–737.
Somasundaram, K., et al. (1997) Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 389, 187–190.
Wang, Q., Zhang, H., Kajino, K., and Greene, M. I. (1998) BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells. Oncogene 17, 1939–1948.
Fan, S., et al. (1999) BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284, 1354–1356.
Scully, R., et al. (1997) BRCA1 is a component of the RNA polymerase II holoenzyme. Proc. Natl. Acad. Sci. USA 94, 5605–5610.
Yu, X., Wu, L. C., Bowcock, A. M., Aronheim, A., and Baer, R. (1998) The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J. Biol. Chem. 273, 25388–25392.
Zhang, H., et al. (1998) BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16, 1713–1721.
Somasundaram, K., et al. (1999) BRCA1 signals ARF-dependent stabilization and coactivation of p53. Oncogene 18, 6605–6614.
Harkin, D. P., et al. (1999) Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97, 575–586.
MacLachlan, T. K., et al. (2000) BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J. Biol. Chem. 275, 2777–2785.
Irminger-Finger, I., et al. (2001) Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis. Mol. Cell 8, 1255–1266.
Marmorstein, L. Y., Ouchi, T., and Aaronson, S. A. (1998) The BRCA2 gene product functionally interacts with p53 and RAD51. Proc. Natl. Acad. Sci. USA 95, 13869–13874.
Zheng, L., et al. (2000) Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1. Mol. Cell 6, 757–768.
Tutt, A., et al. (1999) Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification. Curr. Biol. 9, 1107–1110.
Xu, X., et al. (1999) Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3, 389–395.
Hsu, L. C. and White, R. L. (1998) BRCA1 is associated with the centrosome during mitosis. Proc. Natl. Acad. Sci. USA 95, 12983–12988.
Deming, P. B., et al. (2001) The human decatenation checkpoint. Proc. Natl. Acad. Sci. USA 98, 12044–12049.
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H., and Leadon, S. A. (1998) BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science 281, 1009–1012.
Le Page, F., et al. (2000) BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells [In Process Citation]. Cancer Res. 60, 5548–5552.
Kleiman, F. E. and Manley, J. L. (1999) Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50. Science 285, 1576–1579.
Kleiman, F. E. and Manley, J. L. (2001) The BARD1-CstF-50 interaction links mRNA 3’ end formation to DNA damage and tumor suppression. Cell 104, 743–753.
Henikoff, S. (1997) Nuclear organization and gene expression: homologous pairing and long-range interactions. Curr. Opin. Cell. Biol. 9, 388–395.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Scully, R., Puget, N. (2003). Hereditary Breast and Ovarian Cancer Genes. In: El-Deiry, W.S. (eds) Tumor Suppressor Genes. Methods in Molecular Biology™, vol 222. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-328-3:041
Download citation
DOI: https://doi.org/10.1385/1-59259-328-3:041
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-0-89603-986-5
Online ISBN: 978-1-59259-328-6
eBook Packages: Springer Protocols